Funding Briefs

A task force of communications experts met in January to craft funding priorities for the new NIH arm, the National Institute on Deafness and Other Communication Disorders. One goal for the institute, according to the task force, should be to increase the number of physicians doing research in this field. Noting that less than half of the nation's otolaryngologists are trained to do biomedical research, the task force called for substantially increased training opportunities for scientists and

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

A task force of communications experts met in January to craft funding priorities for the new NIH arm, the National Institute on Deafness and Other Communication Disorders. One goal for the institute, according to the task force, should be to increase the number of physicians doing research in this field. Noting that less than half of the nation's otolaryngologists are trained to do biomedical research, the task force called for substantially increased training opportunities for scientists and allied health specialists interested in investigating hearing disorders. The task force also asked the new institute to focus on little-publicized but common communications disorders such as tinnitus, a chronic ringing in the ears.

(NIDOCD, NIH 301-496-3152)

The Kresge Foundation of Troy, Mich., announced a plan last spring to upgrade and maintain scientific equipment at universities, hospitals, and research institutions, offering up to $20 million in grants over two years. Despite many inquiries, very ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies